Evidence map›Paper›PMID 42206545›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Pharmacy-based triage to preselect high-risk individuals for skin cancer screening: A pilot study.

An Buckinx, Laurence Feldmeyer, Philippa Golling, Carlo Mainetti, Cristina Mangas, Anja Wysocki, Véronique Del Marmol, Regina von Burg, Eva von Wartburg, Stephen P Jenkinson and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

An BuckinxNHKK Commission, Swiss Society of Dermatology and Venereology, Bern, Switzerland.ORCID https://orcid.org/0009-0008-8577-1811
Laurence FeldmeyerDepartment of Dermatology, University Teaching and Research Hospital of the University of Lucerne, Lucerne, Switzerland.
Philippa GollingNHKK Commission, Swiss Society of Dermatology and Venereology, Bern, Switzerland.
Carlo MainettiNHKK Commission, Swiss Society of Dermatology and Venereology, Bern, Switzerland.
Cristina MangasDermatology Department, Ente Ospedaliero Cantonale and Institute of Oncology from South of Switzerland, Bellinzona, Switzerland.
Anja WysockiDepartment of Dermatology, University Teaching and Research Hospital of the University of Lucerne, Lucerne, Switzerland.
Véronique Del MarmolDepartment of Dermatology and Venereology, Hôpital Erasme Université Libre de Bruxelles, Brussels, Belgium.
Regina von BurgInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Eva von WartburgInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Stephen P JenkinsonInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Daniel HohlNHKK Commission, Swiss Society of Dermatology and Venereology, Bern, Switzerland.ORCID https://orcid.org/0000-0001-6337-7110
Olivier GaideNHKK Commission, Swiss Society of Dermatology and Venereology, Bern, Switzerland.ORCID https://orcid.org/0000-0002-2865-7595

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

high‐risk populationsnational campaignpharmacy referralpremalignant lesionspreventionskin cancer

Identifiers

PMID42206545
PMCPMC13613353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.